Fluticasone propionate cream and a method for preparing the same
By using a mixture of hexanediol and propylene glycol as solvents and a composite stabilizer, the problem of inappropriate retention in fluticasone propionate cream was solved, achieving appropriate drug retention and penetration in the skin, improving the stability and therapeutic effect of the cream, and making it suitable for industrial production.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FRONT PHARM PLC
- Filing Date
- 2024-12-30
- Publication Date
- 2026-06-30
AI Technical Summary
In existing fluticasone propionate creams, the poor solubility of fluticasone propionate leads to an inappropriate amount remaining in the skin, affecting the efficacy of the drug and increasing the risk of systemic adverse reactions. Furthermore, the quality stability of existing creams is insufficient.
Fluticasone propionate cream was formulated using a mixture of hexanediol and propylene glycol as solvents and a composite stabilizer (EDTA series salts and pH buffers). Combined with penetration enhancers (such as isopropyl myristate, laurocapram, and oleic acid oil), the cream was prepared through a specific process to ensure that the amount of drug retained and permeated in the skin was appropriate, thereby improving stability.
It achieves an appropriate retention and penetration rate of the drug in the skin, reduces the risk of adverse reactions, and improves the stability and therapeutic effect of the cream, making it suitable for industrial production.
Smart Images

Figure BDA0005217875870000031 
Figure BDA0005217875870000041 
Figure BDA0005217875870000042